Caprock Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Caprock Group’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$714K	Sell	4,512 -229	-5%	-$31K	0.01%	742
2026 Q1	$606K	Hold	4,741	–	–	0.01%	686
2025 Q4	$578K	Sell	4,741 -569	-11%	-$65.2K	0.01%	767
2025 Q3	$477K	Buy	+5,310	New	+$478K	0.01%	822
2025 Q1	$313K	Hold	3,853	–	–	0.01%	855
2024 Q4	$347K	Hold	3,853	–	–	0.01%	748
2024 Q3	$381K	Sell	3,853 -1	-0%	-$98	0.01%	645
2024 Q2	$357K	Sell	3,854 -597	-13%	-$53.5K	0.01%	635
2024 Q1	$422K	Hold	4,451	–	–	0.02%	461
2023 Q4	$398K	Sell	4,451 -1,340	-23%	-$99.5K	0.03%	459
2023 Q3	$423K	Sell	5,791 -3,052	-35%	-$244K	0.03%	399
2023 Q2	$736K	Buy	8,843 +1,155	+15%	+$96.6K	0.05%	274
2023 Q1	$586K	Buy	7,688 +62	+0.8%	+$5.14K	0.05%	325
2022 Q4	$633K	Buy	7,626 +660	+9%	+$53.4K	0.06%	241
2022 Q3	$553K	Buy	6,966 +476	+7%	+$40.1K	0.05%	258
2022 Q2	$482K	Buy	+6,490	New	+$487K	0.05%	273

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Caprock Group's XBI Position: Q2 2026 in Review

Caprock Group reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 4.8% in Q2 2026, selling an estimated $31K and leaving 4,512 shares worth $714K. The position accounts for 0.01% of the portfolio, ranked #742.

Caprock Group first reported a position in XBI in Q2 2022 and has held it in 16 quarters since. The position peaked at $736K in Q2 2023. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Caprock Group held 4,512 shares of State Street SPDR S&P Biotech ETF worth $714K as of Q2 2026.
Caprock Group sold 229 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $31K.
State Street SPDR S&P Biotech ETF made up 0.01% of Caprock Group's portfolio in Q2 2026, its #742 holding.
Caprock Group first reported a position in State Street SPDR S&P Biotech ETF in Q2 2022 and has held it in 16 quarters since.
Caprock Group's State Street SPDR S&P Biotech ETF position peaked at $736K in Q2 2023.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Caprock Group's 13F filing for Q2 2026, filed 27 Jul 2026.